Two biotechs set out for the public markets this week, with Upstream Bio raising $255 million for its inflammatory disease ...
The company claims to have decoded human cell rejuvenation and identified potential gene targets for therapies that treat ...
The PCR technologies market is set to grow from USD 14.61 billion in 2024 to USD 21.89 billion by 2030, at a CAGR of 7.0%, driven ...